Manuel Cerqueira, MD
Nuclear Medicine · Cleveland, OHNPI 1356304232
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $136,693 of the $160,293 with a category attached, or 85.3%. Astellas Pharma US Inc accounts for 70.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $91,929 and has fallen 89.7% since, to $9,444 in 2022.
Across 140 payments — averaging $1144.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$113K
- GE HealthCare$37K
- Pfizer$9K
- Siemens Medical Solutions USA, Inc.$1K
- Agfa Healthcare Corporation$223
- Advanced Accelerator Applications$78
- plus $65 from 2 others
What the payments were for
- Consulting fees$11,1497%
- Speaking & faculty fees$136,69385%
- Travel & lodging$9,5976%
- Food & beverage$2,8532%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 108 | $112,804 |
| GE HealthCare | 6 | $37,040 |
| Pfizer | 4 | $8,901 |
| Siemens Medical Solutions USA, Inc. | 15 | $1,182 |
| Agfa Healthcare Corporation | 1 | $223 |
| Advanced Accelerator Applications | 3 | $78 |
| Bayer | 2 | $40 |
| Blue Earth Diagnostics | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LEXISCAN$5,736
- Biograph Vision$556
- VYNDAMAX$101
How this compares
Too few nuclear medicine providers in Ohioto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nuclear medicine in Cleveland
- Anca AvramCleveland$11K
- Norbert AvrilCleveland$4K
- Jon KotlerColumbus$556
- Martin JacobsKettering$234
- Michael GelfandCincinnati$135
- Nishanta BaidyaDayton$74
- Benedict KimCanton$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.